Raffles Medical Group Ltd
SGX:BSL

Watchlist Manager
Raffles Medical Group Ltd Logo
Raffles Medical Group Ltd
SGX:BSL
Watchlist
Price: 0.83 SGD -0.6% Market Closed
Market Cap: 1.6B SGD
Have any thoughts about
Raffles Medical Group Ltd?
Write Note

Net Margin
Raffles Medical Group Ltd

8.7%
Current
14%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.7%
=
Net Income
60.9m
/
Revenue
701.8m

Net Margin Across Competitors

Country SG
Market Cap 1.6B SGD
Net Margin
9%
Country US
Market Cap 78.1B USD
Net Margin
9%
Country SA
Market Cap 98B SAR
Net Margin
21%
Country ZA
Market Cap 24.1B Zac
Net Margin
19%
Country ZA
Market Cap 20B Zac
Net Margin
6%
Country CN
Market Cap 129.8B CNY
Net Margin
18%
Country MY
Market Cap 63.8B MYR
Net Margin
11%
Country IN
Market Cap 1.1T INR
Net Margin
19%
Country IN
Market Cap 1T INR
Net Margin
5%
Country US
Market Cap 12.2B USD
Net Margin
15%
Country US
Market Cap 11.9B USD
Net Margin
7%
No Stocks Found

Raffles Medical Group Ltd
Glance View

Market Cap
1.5B SGD
Industry
Health Care

In the bustling heart of Singapore, Raffles Medical Group Ltd. has established itself as a cornerstone of the healthcare sector in Asia. Founded in 1976, the company has cultivated a reputation for comprehensive medical services, seamlessly blending the professional expertise and state-of-the-art technology. From its humble origins as a two-doctor clinic, Raffles Medical has expanded into a formidable network, operating over 100 clinics and a renowned tertiary hospital in Singapore. Its operation spans across key Asian markets, including China, Vietnam, and Japan. The company’s focus on providing quality healthcare is evident in its diverse range of services, which include everything from primary care and dental clinics to more specialized services such as radiology and laboratory services. Through a blend of clinical care and innovation, Raffles Medical Group continues to meet the healthcare needs of the growing population in the region. Financially, Raffles Medical Group’s business model is multifaceted, effectively capitalizing on various revenue streams. The company derives its income from both its extensive suite of outpatient and inpatient services. Outpatient services, through its primary care clinics, offer a steady stream of revenue as these clinics handle routine check-ups, vaccinations, and chronic disease management. Inpatient services, provided mainly through Raffles Hospital in Singapore, include surgery, intensive care, and emergency care, catering to an international clientele that values the hospital’s esteemed integrated healthcare model. Additionally, the company diversifies its income with corporate health insurance services, which leverage its medical expertise to provide tailored health insurance plans, thereby enmeshing itself further into the fabric of its clientele's healthcare journey. This diversification not only strengthens the company’s financial foundation but also positions it well for growth in an industry that revolves around the constancy of human health needs.

BSL Intrinsic Value
0.92 SGD
Undervaluation 9%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.7%
=
Net Income
60.9m
/
Revenue
701.8m
What is the Net Margin of Raffles Medical Group Ltd?

Based on Raffles Medical Group Ltd's most recent financial statements, the company has Net Margin of 8.7%.